Cafepharma Today

January 15 2019 - FDA drug reviews running on fumes
FDA drug reviews running on fumes
Congressmen feel BMS-Celgene merger will stifle competition
JPM attendees fed up with high prices in San Francisco
Aimmune says shutdown blocks peanut allergy drug review
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience. Read the latest answer -- about EEOC right to sue letters.

Today's most popular searches:

Current News

submit a press release
Anti-aging startup Juvenescence bags $46M for pipeline push
Fierce Biotech
Wednesday, January 16, 2019 - 10:12am
tags:
Juvenescence, anti-aging, startups
Five Prime Therapeutics Cuts 20% of Staff as Part of Restructuring
BioSpace
Wednesday, January 16, 2019 - 10:08am
tags:
Five Prime Therapeutics, layoffs, restructuring
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter
Xconomy
Wednesday, January 16, 2019 - 10:07am
tags:
Merck, Roger Perlmutter. immuno-oncology
Gottlieb, Marks detail plans to advance development of cell and gene therapies
Endpoints
Wednesday, January 16, 2019 - 10:05am
tags:
FDA, Scott Gottlieb, CBER, cell therapy, gene therapy
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Wednesday, January 16, 2019 - 10:03am
tags:
Janssen, JNJ, Erleada, prostate cancer, Europe
Sanofi expands multitargeting toolbox with Biomunex deal
BioCentury
Wednesday, January 16, 2019 - 12:08am
tags:
Sanofi, Biomunex Pharmaceuticals, drug development
Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there's no connection
Fierce Pharma
Wednesday, January 16, 2019 - 12:06am
tags:
GSK, Shingrix, vaccines, drug shortage, government shutdown
Tribe, Allergan appeal sovereign immunity patent case to Supreme Court
BioCentury
Wednesday, January 16, 2019 - 12:04am
tags:
Allergan, Supreme Court, inter partes review
Copay coupons help (a little) with CV drug adherence but not outcomes: study
Fierce Pharma
Wednesday, January 16, 2019 - 12:02am
tags:
copay coupons, heart attacks
Walgreens CEO: Microsoft Will Help Create 'Ecosystem' To Simplify Healthcare
Forbes
Tuesday, January 15, 2019 - 11:59pm
tags:
Microsoft, Walgreens Boots Alliance
Bioharmony, Boehringer partner to develop antimicrobials
BioCentury
Tuesday, January 15, 2019 - 11:57pm
tags:
Boehringer Ingelheim, Bioharmony Therapeutics, antimicrobials
‘A blizzard of prescriptions’: Documents reveal new details about Purdue’s marketing of OxyContin
Stat
Tuesday, January 15, 2019 - 11:54pm
tags:
Purdue Pharma, oxycontin
FDA drug reviews running on fumes
BioCentury
Tuesday, January 15, 2019 - 11:28am
tags:
FDA, drug reviews, Scott Gottlieb, government shutdown
Congressmen to regulators: BMS-Celgene merger will stifle competition and raise drug prices
Fierce Pharma
Tuesday, January 15, 2019 - 11:25am
tags:
US Congress, M&A, Bristol-Myers Squibb, Celgene, drug pricing
AI Picks Out 'Shapeshifting' Cancer Cells, Revealing Potential New Drug Targets
Forbes
Tuesday, January 15, 2019 - 11:19am
tags:
artificial intelligence, ovarian cancer, diagnostics
Harvard prof David Sinclair backs anti-aging upstart Life Bio, which just raised $50M for research
Endpoints
Tuesday, January 15, 2019 - 11:14am
tags:
Life Biosciences, anti-aging, Harvard, startups
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
Fierce Biotech
Tuesday, January 15, 2019 - 11:09am
tags:
EMA, Europe, Brexit, UK, Amsterdam
Want to win over payers, pharma? Forget the 'me-too' drugs, CSL chief says
Fierce Pharma
Tuesday, January 15, 2019 - 11:06am
tags:
CSL, Paul Perreault, me-too drugs, payers
In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica
Endpoints
Tuesday, January 15, 2019 - 10:08am
tags:
China, FDA, Btk inhibitors, BeiGene, cancer
Attendees fed up with venue, high prices call to move JPM out of San Francisco
Fierce Biotech
Tuesday, January 15, 2019 - 10:03am
tags:
JPMHC 2019

Pages

Latest CP Wire Articles

European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease
Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders
Atlantic Therapeutics Raises $32 Million in Series B Financing After FDA Approves is Device to Treat Incontinence
Ribon Therapeutics Raises $65 Million to Advance Novel Cancer Pipeline
Ablative Solutions Banks $77 Million in Series D Funding for Unique Approach to Treating Uncontrolled Hypertension
Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program
Orphan Drug Designation Granted to Investigational Gene Therapy for Rare Form of Muscular Dystrophy

Latest Pharmagather Articles

Digital Visionary: Andre Heeg, Sandoz
pharmexec technology
Nivien’s Shot
In the Pipeline
Independent Pharmacy Economics Keep Deteriorating
Drug Channels
A Toxicological Flag
In the Pipeline
CBI’s 6th Annual e-Rx and EHR
Drug Channels
Aligning Tactics with the Goals of Value-Based Care
pharmexec marketing
Learning, Retaining, Applying Information: Preparing Reps for Success in the Field
pharmexec marketing
FDA Sets Records in Approving More New Drugs
pharmexec r&d
Come One, Come All to These Kinases
In the Pipeline
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Cytel Names Joshua Schultz as Chief Executive Officer
Wednesday, January 16, 2019 - 9:00am
Kannalife Announces Completion of Name Change, Ticker Symbol Change
Wednesday, January 16, 2019 - 9:00am
Capstone Secures Follow-Up Order From Leading Global Pharmaceutical Company to Provide 1.4 MW of Clean Energy for Sensitive Manufacturing Process
Wednesday, January 16, 2019 - 8:30am
Fibrocell to Present at Phacilitate Leaders World 2019
Wednesday, January 16, 2019 - 8:00am
Onconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive Officer
Tuesday, January 15, 2019 - 5:15pm
Progressive Care Inc. Announces Best December in Company History
Tuesday, January 15, 2019 - 8:00am
Denis Corin, CEO, of Q BioMed Inc. Provides Key Update and Outlook in a New Audio Interview with SmallCapVoice.com
Tuesday, January 15, 2019 - 8:00am
Uptick Newswire Hosts The President and CEO of CytoDyn Inc. to Discuss The Incredible Potential Breakthroughs The Company is Working Towards in HIV and Cancer Treatment
Monday, January 14, 2019 - 8:30am
Arrayit Corporation Aces Fourth Consecutive Round of Proficiency Testing with a Top Proficiency Testing Company
Monday, January 14, 2019 - 5:30am
Progressive Care Executes New Capital Funding Facility
Friday, January 11, 2019 - 8:00am

Breaking Healthcare News - powered by Seeking Alpha

Cross Country Healthcare names Kevin Clark as President and CEO
Wednesday, January 16, 2019 - 9:44am
AxoGen commercial chief bids adieu
Wednesday, January 16, 2019 - 9:28am
Medical Marijuana launches new hemp oil product
Wednesday, January 16, 2019 - 9:24am
Pain Therapeutics up 13% on receiving $1.5M grant
Wednesday, January 16, 2019 - 9:19am
Aeterna Zentaris' macimorelin OK'd in Europe; shares up 1% premarket
Wednesday, January 16, 2019 - 9:18am
Abbott to acquire Cephea Valve Technologies
Wednesday, January 16, 2019 - 9:12am
Viveve sees FY 2018 revenue as high as $18.5M; shares up 21% premarket
Wednesday, January 16, 2019 - 8:58am
Walgreens, Microsoft sign major cloud deal
Tuesday, January 15, 2019 - 8:58am
CEL-SCI regains full listing compliance with NYSE
Tuesday, January 15, 2019 - 8:55am
Menlo Therapeutics’ serlopitant a Breakthrough Therapy for pruritus
Tuesday, January 15, 2019 - 8:46am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.